Zynerba Pharmaceuticals, Inc.’s $50.4 Million Public Offering of Common Shares

Ambrogio Visconti

Hogan Lovells is representing Zynerba Pharmaceuticals, Inc. (ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, in a public…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now